FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569446437> ?p ?o ?g. }

• W1569446437 endingPage "182" @default.
• W1569446437 startingPage "173" @default.
• W1569446437 abstract "In an effort to identify the human cytochromes P450 involved in the N-demethylation of dextromethorphan, the kinetics of 3-methoxymorphinan formation were studied in microsomal enzyme systems. Under initial rate conditions, 3-methoxymorphinan formation demonstrated single enzyme Michaelis-Menten kinetics using microsomes obtained from three human livers (Km: 0.52–0.71 mM; Vmax: 375–812 pmol/mg protein/min). B-lymphoblastoid cells expressing CYP3A4 incubated with 0.4 mM dextromethorphan catalyzed the formation of 3-methoxymorphinan at a rate of 22 pmol product/mg protein/min. Midazolam, a prototypic substrate for CYP3A4 and CYP3A5, competitively inhibited dextromethorphan N-demethylation by two human liver microsomal samples with Ki values of 46 ± 10 and 63 ± 8 μM. At a dextromethorphan concentration of 0.4 mM, gestodene (100 μM) inhibited 3-methoxymorphinan formation by approximately 50%. Immunoinhibition of dextro-methorphan N-demethylation using rabbit anti-CYP3A4 antibodies resulted in a 60% decrease in 3-methoxymorphinan formation at a dextromethorphan concentration of 0.4 mM. Additional inhibition studies using furafylline, coumarin, sulfaphenazole, mephenytoin, quinidine, and diethyldithiocarbamic acid, which are selective inhibitors of CYP1A2, CYP2A6, CYP2C8/9, CYP2Cmp, CYP2D6, and CYP2E1, respectively, demonstrated no substantial inhibition of dextromethorphan N-demethylation. Correlation analysis was performed using the rate of 3-methoxymorphinan formation at a concentration of 1mM dextromethorphan and immunoquantified levels of CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4, and CYP3A5 and their associated characteristic catalytic activities. A significant correlation was observed between dextromethorphan N-demethylase activity and midazolam 1'- and 4-hydroxylase activity (r2 = 0.77 and 0.69 respectively, N = 19, P < 0.01); the exclusion of those samples containing both CYP3A4 and CYP3A5 increased the correlation significantly (r2 = 0.87 and 0.91 respectively, N = 12, P < 0.01). In the absence of CYP3A5, a significant correlation was observed between 3-methoxymorphinan formation and the sample's erythromycin N-demethylase activity (r2= 0.94, N = 12, P < 0.01), testosterone 6 β-hydroxylase activity (r2 = 0.96, N = 7, P < 0.01) and relative immunoquantified levels of CYP3A4 (r2 = 0.96, N = 12, P < 0.01). Inclusion of those samples expressing CYP3A5 in addition to CYP3A4 reduced the magnitude of the observed correlation. No significant correlation between 3-methoxymorphinan formation and the sample's relative immunoquantified levels of or form-selective activity associated with CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19 (or CYP2Cmp), CYP2D6, and CYP2E1 was observed. In conclusion, dextromethorphan N-demethylation appears to be catalyzed primarily by CYP3A4 and to a lesser extent by CYP3A5 in vitro in humans. Thus, the administration of dextromethorphan to human volunteers may provide a means of simultaneously phenotyping the in vivo activity of CYP2D6 and CYP3A." @default.
• W1569446437 created "2016-06-24" @default.
• W1569446437 creator A5021185845 @default.
• W1569446437 creator A5047722150 @default.
• W1569446437 creator A5075231467 @default.
• W1569446437 creator A5083182269 @default.
• W1569446437 date "1994-07-01" @default.
• W1569446437 modified "2023-10-18" @default.
• W1569446437 title "Characterization of dextromethorphan N-demethylation by human liver microsomes" @default.
• W1569446437 cites W1526269646 @default.
• W1569446437 cites W1563004338 @default.
• W1569446437 cites W1590889826 @default.
• W1569446437 cites W1775749144 @default.
• W1569446437 cites W1951469402 @default.
• W1569446437 cites W1968196906 @default.
• W1569446437 cites W1984526747 @default.
• W1569446437 cites W1985984753 @default.
• W1569446437 cites W1988858173 @default.
• W1569446437 cites W1993558201 @default.
• W1569446437 cites W1998164049 @default.
• W1569446437 cites W2001350377 @default.
• W1569446437 cites W2014884679 @default.
• W1569446437 cites W2022382730 @default.
• W1569446437 cites W2029160941 @default.
• W1569446437 cites W2033008571 @default.
• W1569446437 cites W2048297335 @default.
• W1569446437 cites W2051175552 @default.
• W1569446437 cites W2055568229 @default.
• W1569446437 cites W2056627166 @default.
• W1569446437 cites W2065675076 @default.
• W1569446437 cites W2075704939 @default.
• W1569446437 cites W2078427294 @default.
• W1569446437 cites W2081801838 @default.
• W1569446437 cites W2083675642 @default.
• W1569446437 cites W2084449553 @default.
• W1569446437 cites W2102968881 @default.
• W1569446437 cites W2120917180 @default.
• W1569446437 cites W2142869955 @default.
• W1569446437 cites W2169290209 @default.
• W1569446437 cites W2335881284 @default.
• W1569446437 cites W2412128606 @default.
• W1569446437 doi "https://doi.org/10.1016/0006-2952(94)90237-2" @default.
• W1569446437 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8043020" @default.
• W1569446437 hasPublicationYear "1994" @default.
• W1569446437 type Work @default.
• W1569446437 sameAs 1569446437 @default.
• W1569446437 citedByCount "112" @default.
• W1569446437 countsByYear W15694464372012 @default.
• W1569446437 countsByYear W15694464372013 @default.
• W1569446437 countsByYear W15694464372014 @default.
• W1569446437 countsByYear W15694464372015 @default.
• W1569446437 countsByYear W15694464372019 @default.
• W1569446437 countsByYear W15694464372020 @default.
• W1569446437 countsByYear W15694464372021 @default.
• W1569446437 countsByYear W15694464372022 @default.
• W1569446437 crossrefType "journal-article" @default.
• W1569446437 hasAuthorship W1569446437A5021185845 @default.
• W1569446437 hasAuthorship W1569446437A5047722150 @default.
• W1569446437 hasAuthorship W1569446437A5075231467 @default.
• W1569446437 hasAuthorship W1569446437A5083182269 @default.
• W1569446437 hasConcept C104317684 @default.
• W1569446437 hasConcept C109650736 @default.
• W1569446437 hasConcept C140027455 @default.
• W1569446437 hasConcept C150194340 @default.
• W1569446437 hasConcept C181199279 @default.
• W1569446437 hasConcept C185592680 @default.
• W1569446437 hasConcept C190727270 @default.
• W1569446437 hasConcept C196013638 @default.
• W1569446437 hasConcept C202199734 @default.
• W1569446437 hasConcept C2776658834 @default.
• W1569446437 hasConcept C2779591118 @default.
• W1569446437 hasConcept C2780339425 @default.
• W1569446437 hasConcept C2781245242 @default.
• W1569446437 hasConcept C526171541 @default.
• W1569446437 hasConcept C55493867 @default.
• W1569446437 hasConcept C86745063 @default.
• W1569446437 hasConcept C86803240 @default.
• W1569446437 hasConcept C87644729 @default.
• W1569446437 hasConcept C98274493 @default.
• W1569446437 hasConceptScore W1569446437C104317684 @default.
• W1569446437 hasConceptScore W1569446437C109650736 @default.
• W1569446437 hasConceptScore W1569446437C140027455 @default.
• W1569446437 hasConceptScore W1569446437C150194340 @default.
• W1569446437 hasConceptScore W1569446437C181199279 @default.
• W1569446437 hasConceptScore W1569446437C185592680 @default.
• W1569446437 hasConceptScore W1569446437C190727270 @default.
• W1569446437 hasConceptScore W1569446437C196013638 @default.
• W1569446437 hasConceptScore W1569446437C202199734 @default.
• W1569446437 hasConceptScore W1569446437C2776658834 @default.
• W1569446437 hasConceptScore W1569446437C2779591118 @default.
• W1569446437 hasConceptScore W1569446437C2780339425 @default.
• W1569446437 hasConceptScore W1569446437C2781245242 @default.
• W1569446437 hasConceptScore W1569446437C526171541 @default.
• W1569446437 hasConceptScore W1569446437C55493867 @default.
• W1569446437 hasConceptScore W1569446437C86745063 @default.
• W1569446437 hasConceptScore W1569446437C86803240 @default.
• W1569446437 hasConceptScore W1569446437C87644729 @default.
• W1569446437 hasConceptScore W1569446437C98274493 @default.

• next